Overview

Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial

Status:
Unknown status

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

Summary

after endoscopic submucosal dissection(ESD) of early gastric cancer, conventional proton pump(PPI) inhibitors and H2 receptor antagonists have a controversial effect on preventing bleeding from artificial ulcers. the aim of this study was to investigate whether a stronger acid suppression (high dose PPI) more effectively prevents bleeding after ESD

Phase:

N/A

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

Histamine H2 Antagonists
Pantoprazole
Proton Pump Inhibitors